apple over-concentration
2 years ago
Published September 18, 2022 by

He's protecting clients from over-concentration in Apple

From Brenda Bouw's "Why this portfolio manager sold Apple stock to buy into pharmaceuticals" ($) in Saturday's Toronto Globe and Mail.

For more, please login or subscribe